Bristol-Myers, AstraZeneca drug helps treat rare disease
This article was originally published in Scrip
Executive Summary
An experimental treatment being developed by Bristol-Myers Squibb and AstraZeneca helped treat children with a rare condition that causes uncontrolled loss of fat tissue.